Margaret A. Eichleay
Arbor Research Collaborative for Health
315 W. Huron St. Suite 360
Ann Arbor, MI 48103
NBER Working Papers and Publications
|May 2007||End-stage Renal Disease and Economic Incentives: The International Study of Health Care Organization and Financing|
with Avi Dor, Mark V. Pauly, Philip J. Held: w13125
End-stage renal disease (ESRD), or kidney failure, is a debilitating, costly, and increasingly common medical condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with alternative models of incentives and benefits, collected under the International Study of Health Care Organization and Financing, a substudy within the Dialysis Outcomes and Practice Patterns Study. Variation in spending per ESRD patient is relatively small and is correlated with overall per capita health care spending. Between-country variations in spending are reduced using an input price parity index constructed for this study. Remaining differences in costs and outcomes do not seem strongly link...
Published: Avi Dor & Mark Pauly & Margaret Eichleay & Philip Held, 2007. "End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF)," International Journal of Health Care Finance and Economics, Springer, vol. 7(2), pages 73-111, September.